Table 3.
ligand | steady state parametersa | equilibrium bindingb | ||||
---|---|---|---|---|---|---|
Km app (μM) | Hill coefficient | kcat (s−1) | Ki app (μM) | Hill coefficient | Kd (μM) | |
NADPH | 3.5 ± 0.2 | 2.5 ± 0.5 | 0.082 ± 0.002c | – | 1.0d | 2.7 ± 0.2d |
NADPH | 3.7 ± 0.2 | 2.6 ± 0.3 | 0.082 ± 0.002c | – | ||
DAB | 1.6 ± 0.3e | 1.0e | 0.0127 ± 0.009e | 14 ± 2e | ||
DAB | 1.2 ± 0.2f | 1.0f | 0.014 ± 0.01f | 108 ± 67f |
Fit to eq 1 or 2 in Experimental Procedures.
NADPH binding fit to eq 4 in Experimental Procedures.
Based on a NADPH saturation curve with DAB not fully saturated.
Based on intrinsic tryptophan fluorescence quenching and fit to equation 6 (see Figure 3C).
Based on DAB saturation kinetics with 10Kd of NADPH.
Based on DAB saturation kinetics with 200Kd of NADPH.